4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-26-008338
CVP, TAVR sold 619 shares at $85.65 ($53,017)
- CVP, TAVR acquired 619 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lippis Daniel J. · CVP, TAVR
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +619 | $72.68 | $44,989 | 40,652.91 | D |
| 2026-10-08 | Sale : show line 2 in the form 10b5-1 | −619 | $85.65 | $53,017 | 40,033.91 | D |
| Open-market sales · 619 sh · avg $85.65 · $53,017 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-08 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −619 | 3,095 | D |
Loading xslF345X06/doc4.xml…